Citigroup’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $923K | Sell |
22,794
-12,996
| -36% | -$526K | ﹤0.01% | 2565 |
|
|
2025
Q1 | $1.84M | Sell |
35,790
-2,418
| -6% | -$124K | ﹤0.01% | 2144 |
|
|
2024
Q4 | $2.12M | Buy |
38,208
+4,773
| +14% | +$264K | ﹤0.01% | 2095 |
|
|
2024
Q3 | $1.1M | Buy |
33,435
+17,685
| +112% | +$582K | ﹤0.01% | 2496 |
|
|
2024
Q2 | $428K | Buy |
15,750
+1,628
| +12% | +$44.2K | ﹤0.01% | 2789 |
|
|
2024
Q1 | $513K | Buy |
14,122
+2,142
| +18% | +$77.9K | ﹤0.01% | 2840 |
|
|
2023
Q4 | $243K | Buy |
11,980
+7,830
| +189% | +$159K | ﹤0.01% | 3101 |
|
|
2023
Q3 | $73.7K | Sell |
4,150
-3,913
| -49% | -$69.5K | ﹤0.01% | 3338 |
|
|
2023
Q2 | $146K | Buy |
8,063
+7,323
| +990% | +$132K | ﹤0.01% | 3388 |
|
|
2023
Q1 | $9.3K | Sell |
740
-159
| -18% | -$2K | ﹤0.01% | 4099 |
|
|
2022
Q4 | $13.2K | Buy |
899
+620
| +222% | +$9.09K | ﹤0.01% | 4040 |
|
|
2022
Q3 | $5K | Sell |
279
-944
| -77% | -$16.9K | ﹤0.01% | 4464 |
|
|
2022
Q2 | $18K | Buy |
1,223
+907
| +287% | +$13.3K | ﹤0.01% | 4373 |
|
|
2022
Q1 | $5K | Sell |
316
-1,829
| -85% | -$28.9K | ﹤0.01% | 5019 |
|
|
2021
Q4 | $48K | Buy |
2,145
+1,183
| +123% | +$26.5K | ﹤0.01% | 4321 |
|
|
2021
Q3 | $21K | Buy |
962
+561
| +140% | +$12.2K | ﹤0.01% | 4472 |
|
|
2021
Q2 | $12K | Sell |
401
-12
| -3% | -$359 | ﹤0.01% | 4911 |
|
|
2021
Q1 | $13K | Sell |
413
-738
| -64% | -$23.2K | ﹤0.01% | 4832 |
|
|
2020
Q4 | $48K | Buy |
+1,151
| New | +$48K | ﹤0.01% | 4123 |
|